|
Women's Antioxidant and Cardiovascular Study (WACS) Clinical Trials Information presented on Clinical Trials Search isn't designed to be a substitute for certified healthcare advice, travels to or professional assistance using a genuine medical doctor. We are not physicians. Always confer with your dr. about Women's Antioxidant and Cardiovascular Study (WACS) conditions. Clinical Trials Search.org is a site devoted to listing clinical research studies in human subjects. Women's Antioxidant and Cardiovascular Study (WACS) Clinical research trials and Women's Antioxidant and Cardiovascular Study (WACS) medical trials happen in hundreds of places across the United States. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials usually measure the effectualness of new drugs. The intention of the studies / undertakings is to solve certain human healthcare questions. Clinical trials are a popular manner for mDs, government agencies, and private sector companies to locate treatments for all forms of circumstances, such as Women's Antioxidant and Cardiovascular Study (WACS). Women's Antioxidant and Cardiovascular Study (WACS) Clinical Trials and other clinical trials allow for volunteers to undergo medical treatment choices before they are available to the general public. Some times the human subjects get treatment for free of charge, and sometimes they are paid for their time. Occasionally there is a cost for a Women's Antioxidant and Cardiovascular Study (WACS) clinical trial. Participants frequently get the best healthcare available for their Women's Antioxidant and Cardiovascular Study (WACS) condition. Risks are a reality, nonetheless, and can include extra or frequent physician trips, medical risks (possibly life-jeopardising), and/or the treatment being ineffective. Trials are federally governed with exacting guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > "W" Clinical Trials Conditions > Women's Antioxidant and Cardiovascular Study (WACS)  Women's Antioxidant and Cardiovascular Study (WACS)
Women's Antioxidant and Cardiovascular Study (WACS)
For Condition: Cardiovascular Diseases,Coronary Arteriosclerosis,Coronary Disease,Heart Diseases,Myocardial Infarction,Myocardial Ischemia
Status: No longer recruiting
Sponsor(s): National Heart, Lung, and Blood Institute (NHLBI) ,
Synopsis: To determine if supplements of vitamin C, vitamin E, and beta-carotene reduce all major cardiovascular events in high risk women with a prior history of atherosclerotic cardiovascular disease. The trial is piggybacked on the Women's Health Study (WHS), a primary prevention trial of vitamin Eand aspirin in a low risk population of women.
Details: BACKGROUND: The antioxidant properties of vitamin C, vitamin E, and beta-carotene are well known and are postulated to prevent lipoprotein oxidation and thereby prevent or retard atherogenesis. Based on the successful experience with the Physicians' Health Study, the results of a pilot study conducted in nurses, and long-term experience following a large cohort of United States nurses, the study should provide either definitive positive or informative null results regarding the study hypothesis. DESIGN NARRATIVE: Subjects were randomized in a 2 x 2 x 2 factorial design to 500 mg of vitamin C or placebo daily, 600 mg of vitamin E or placebo on alternate days and/or 50 mg of beta-carotene or placebo on alternate days. There was a three month run-in phase in which eligible patients received placebo caplets. Subjects were randomized only if they reported good compliance, willingness to continue in the trial, had no history of cancer, active liver disease, or use of coumadin, and expressed continued willingness to forego the use of beta-carotene and vitamin A, C, or E supplements. Baseline dietary assessments were made using food frequency questionnaires and information was obtained on aspirin and postmenopausal hormone use at entry and during followup. Subjects were randomized with a stratification by age into eight five-year increments, one being 75+. Endpoints are followed by mail for four years and include all major cardiovascular events such as non-fatal myocardial infarction, non-fatal stroke, a coronary revascularization procedure, and cardiovascular mortality. The trial is conducted as a companion to the Women's Health Study (WHS), a large randomized trial assessing the efficacy of low-dose aspirin and vitamin E in the primary prevention of cardiovascular disease and cancer among apparently healthy women. The trial is currently in treatment and follow-up which continues till February 2006. Starting in May 1998 the protocol was modified to include a folate B6/B12 arm.
Eligibility:
Study Type: Interventional, Prevention, Randomized, Placebo Control, Factorial Assignment
Minimum Age/Maximum Age: 40 Years/
Genders: Female
Protocol Entry Criteria: Women, aged 40 and over, at high risk, with a history of coronary artery disease, carotid endarterectomy, peripheral artery surgery, or three or more coronary heart disease risk factors.
Total Enrollment:
Location and Contact Information:
Overall Study Official:
JoAnnManson, , Brigham and Women's Hospital
Additional Information:
Study ID Numbers: 84;
Study Start Date: May 1993
Record last reviewed: April 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00000541
Other Cardiovascular Diseases Studies:
1. Family Blood Pressure Program - HyperGEN
2. Coronary-Prone Behavior and Cardiovascular Reactivity
3. Family Heart Study - Subclinical Atherosclerosis Network (FHS-SCAN)
4. Central Obesity and Disease Risk in Japanese Americans
5. Percutaneous Transluminal Coronary Angioplasty (PTCA) Registries I, II, and III and the Dynamic Registry
Related Studies:
Other Cardiovascular Diseases Clinical Trials
Other Clinical Trials
Other Clinical Trials
Women's Antioxidant and Cardiovascular Study (WACS)
|
|
|
|
|
|
|
|
